Submission Details
| 510(k) Number | K121981 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 06, 2012 |
| Decision Date | March 21, 2013 |
| Days to Decision | 258 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K121981 is an FDA 510(k) clearance for the ADVIA CENTAUR INACT PARATHYROID HORMONE (IPTH) ASSAY, a Radioimmunoassay, Parathyroid Hormone (Class II — Special Controls, product code CEW), submitted by Siemens Healthcare Diagnostics (New York, US). The FDA issued a Cleared decision on March 21, 2013, 258 days after receiving the submission on July 6, 2012. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1545.
| 510(k) Number | K121981 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 06, 2012 |
| Decision Date | March 21, 2013 |
| Days to Decision | 258 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CEW — Radioimmunoassay, Parathyroid Hormone |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1545 |